It is not necessary to restrict corporate valuation methods to earnings alone. An accepted alternative is to calculate value based upon reported annual revenue numbers. This is particularly appropriate for companies not yet profitable.
The current average market price-to-revenue multiple for established drug-based US biotechnology companies is x 7.74.
Growth companies normally are valued on market using perceived financial numbers at least a couple of years into the future. Cellmid has indicated targeted revenue of around $4 million for this financial year, with year-on-year growth of at least 100%. This would result in revenue around $16 million for FY2018.
Application of the US price/revenue multiple on this figure then would indicate a market cap of $124 million, or current fair value of 13 cents per share.
If the April revenue figure from Japan is representative of how the OTC business is growing, the above valuation would be conservative.
- Forums
- ASX - By Stock
- AN1
- Ann: Update on Japanese Sales-CDY.AX
Ann: Update on Japanese Sales-CDY.AX, page-58
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1197315 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 184156 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1197315 | 0.007 |
5 | 865639 | 0.006 |
1 | 300000 | 0.005 |
3 | 825000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 184156 | 3 |
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
Last trade - 09.59am 15/08/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online